-
公开(公告)号:US20210221806A1
公开(公告)日:2021-07-22
申请号:US16754175
申请日:2018-10-08
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Steven P. SEITZ , Emily Charlotte CHERNEY , Xiau ZHU
IPC: C07D471/04 , C07D307/94 , C07D405/06 , C07K16/28
Abstract: The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.